Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05767450

Intervention on New Onset-T1D Children

Assessing the Role of the Gut Microbiome and of the Intestinal Barrier Integrity in the Immune Pathogenesis of Type 1 Diabetes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
7 Years – 17 Years
Healthy volunteers
Not accepted

Summary

A pilot proof of concept clinical trial will be performed to demonstrate the restoration of gut barrier integrity by administration of beneficial anti-inflammatory gut microbial strains (Lactobacilli-enriched Vivomixx® probiotic) to new onset Type 1 Diabetes Children.

Detailed description

This is an interventional randomized, 2-arm, single-blind, single-center, placebo-controlled mechanistic clinical trial (1:1). One sachet of probiotic for children \< 10 years old or two sachets for subjects \> 10 years old dissolved into water or noncarbonated drinks will be administered every day for 90 consecutive days.The primary end point of the study will be the preservation of the residual insulin-producing beta-cell mass measured as the change in C-peptide values at 12 months after the beginning of treatment. Moreover, the investigators will collect blood samples for serological analysis (autoantibodies detection, measurement of biomarkers of gut barrier integrity) and immunological profiling; fecal samples for microbiome and metabolomic analysis. Finally the investigators will assess whether the response to Vivomixx® probiotic remains stable over a long-term period, that is in the absence of active treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic Vivomixx®The correct number of Vivomixx® sachets are given to parents with the indication to administer the dietary supplement as dissolved in drinking water or non-carbonated drinks.
DIETARY_SUPPLEMENTPlaceboThe correct number of Placebo sachets are given to parents with the indication to administer the dietary supplement as dissolved in drinking water or non-carbonated drinks.

Timeline

Start date
2022-12-16
Primary completion
2025-06-30
Completion
2025-12-31
First posted
2023-03-14
Last updated
2024-12-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05767450. Inclusion in this directory is not an endorsement.